ATE497009T1 - 3-nichttranslatierte hybridbereiche mit eignung zur effizienten proteinexpression in säugerzellen - Google Patents
3-nichttranslatierte hybridbereiche mit eignung zur effizienten proteinexpression in säugerzellenInfo
- Publication number
- ATE497009T1 ATE497009T1 AT05819306T AT05819306T ATE497009T1 AT E497009 T1 ATE497009 T1 AT E497009T1 AT 05819306 T AT05819306 T AT 05819306T AT 05819306 T AT05819306 T AT 05819306T AT E497009 T1 ATE497009 T1 AT E497009T1
- Authority
- AT
- Austria
- Prior art keywords
- hybrid
- region
- efficient
- protein expression
- translated
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title 1
- 108020005345 3' Untranslated Regions Proteins 0.000 abstract 2
- 108091036066 Three prime untranslated region Proteins 0.000 abstract 2
- 108020004999 messenger RNA Proteins 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 108700026244 Open Reading Frames Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 230000008488 polyadenylation Effects 0.000 abstract 1
- 230000010473 stable expression Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000010474 transient expression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2005/013316 WO2007068265A1 (en) | 2005-12-12 | 2005-12-12 | Hybrid 3’ untranslated regions suitable for efficient protein expression in mammalian cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE497009T1 true ATE497009T1 (de) | 2011-02-15 |
Family
ID=35892431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05819306T ATE497009T1 (de) | 2005-12-12 | 2005-12-12 | 3-nichttranslatierte hybridbereiche mit eignung zur effizienten proteinexpression in säugerzellen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9017965B2 (de) |
| EP (1) | EP1974042B1 (de) |
| AT (1) | ATE497009T1 (de) |
| AU (1) | AU2005339232A1 (de) |
| CA (1) | CA2632900A1 (de) |
| DE (1) | DE602005026186D1 (de) |
| IL (1) | IL191995A0 (de) |
| WO (1) | WO2007068265A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012019630A1 (en) | 2010-08-13 | 2012-02-16 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein |
| HK1202578A1 (en) * | 2011-12-07 | 2015-10-02 | Ichnos Sciences SA | Expression cassette |
| WO2013120499A1 (en) | 2012-02-15 | 2013-08-22 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen |
| MX362981B (es) | 2012-03-27 | 2019-02-28 | Curevac Ag | Moleculas artificiales de acido nucleico para la expresion mejorada de proteina o peptido. |
| CN111304231A (zh) * | 2013-12-30 | 2020-06-19 | 库瑞瓦格股份公司 | 人工核酸分子 |
| EP3842537A1 (de) * | 2013-12-30 | 2021-06-30 | CureVac AG | Künstliche nukleinsäuremoleküle |
| US11254951B2 (en) | 2014-12-30 | 2022-02-22 | Curevac Ag | Artificial nucleic acid molecules |
| PT4023755T (pt) * | 2014-12-12 | 2023-07-05 | CureVac SE | Moléculas de ácido nucleico artificiais para uma expressão melhorada de proteína |
| EP3240558A1 (de) * | 2014-12-30 | 2017-11-08 | CureVac AG | Künstliche nukleinsäuremoleküle |
| WO2017059902A1 (en) * | 2015-10-07 | 2017-04-13 | Biontech Rna Pharmaceuticals Gmbh | 3' utr sequences for stabilization of rna |
| US12344864B2 (en) | 2019-10-17 | 2025-07-01 | Public University Corporation Nagoya City University | Artificially synthesized mRNA and use of same |
| EP4450628A4 (de) * | 2021-12-13 | 2025-10-22 | Sml Biopharm Co Ltd | Nukleinsäureexpressionsplattform mit erhöhter expressionseffizienz |
| CN116064663A (zh) * | 2022-09-15 | 2023-05-05 | 思鹏生物科技(苏州)有限公司 | 利用rps基因促进载体稳定表达的方法及其功能基因 |
| WO2025160191A2 (en) * | 2024-01-22 | 2025-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Composition and method for autonomous rna switches for translational control |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7598079B2 (en) | 1998-12-24 | 2009-10-06 | Novation Pharmaceuticals, Inc. | Assay for identifying compounds which affect stability of mRNA |
-
2005
- 2005-12-12 AT AT05819306T patent/ATE497009T1/de not_active IP Right Cessation
- 2005-12-12 US US12/097,169 patent/US9017965B2/en not_active Expired - Fee Related
- 2005-12-12 DE DE602005026186T patent/DE602005026186D1/de not_active Expired - Lifetime
- 2005-12-12 CA CA002632900A patent/CA2632900A1/en not_active Abandoned
- 2005-12-12 WO PCT/EP2005/013316 patent/WO2007068265A1/en not_active Ceased
- 2005-12-12 AU AU2005339232A patent/AU2005339232A1/en not_active Abandoned
- 2005-12-12 EP EP05819306A patent/EP1974042B1/de not_active Expired - Lifetime
-
2008
- 2008-06-05 IL IL191995A patent/IL191995A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1974042A1 (de) | 2008-10-01 |
| AU2005339232A1 (en) | 2007-06-21 |
| US20090181427A1 (en) | 2009-07-16 |
| IL191995A0 (en) | 2008-12-29 |
| WO2007068265A1 (en) | 2007-06-21 |
| US9017965B2 (en) | 2015-04-28 |
| DE602005026186D1 (de) | 2011-03-10 |
| CA2632900A1 (en) | 2007-06-21 |
| EP1974042B1 (de) | 2011-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL191995A0 (en) | Hybrid 3' untranslated regions suitable for efficient protein expression in mammalian cells | |
| BRPI0514396A2 (pt) | polipeptìdeos dependentes de vitamina k modificada | |
| CY1112323T1 (el) | Παραγωγη και καθαρισμος της il-29 | |
| WO2019139645A3 (en) | High efficiency base editors comprising gam | |
| EA201301350A1 (ru) | Модифицированные полипептиды фактора vii и их применение | |
| BRPI0806578A8 (pt) | Promotores de lactococcus e usos dos mesmos | |
| DE602004030315D1 (de) | Induzierbare sirna expressionskonstrukte zur gezielten genabschaltung | |
| PH12013502425B1 (en) | Smoothened polypeptides and methods of use | |
| DE59903410D1 (de) | Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung | |
| EA200802289A1 (ru) | Направляемые к мишени антителами цитокины для терапии | |
| ATE529442T1 (de) | Verbesserte humane interferon-moleküle und ihre verwendungen | |
| BRPI0510475B8 (pt) | adenovírus quimérico recombinante, uso do mesmo no tratamento de câncer e métodos de inibição de crescimento de uma célula de câncer, de fornecimento de uma proteína terapêutica a uma célula e para o isolamento do adenovírus | |
| WO2011036442A3 (en) | Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders | |
| MX2022014162A (es) | Proteínas de fusión de la proteína de la espícula del coronavirus estabilizadas. | |
| WO2020186207A8 (en) | Non-viral dna vectors and uses thereof for expressing fviii therapeutics | |
| IN2012DN02981A (de) | ||
| WO2021178481A8 (en) | Protein nanoparticle design and application | |
| DE60117998D1 (de) | Mutierte furin polypeptide, welche verbesserte eigenschaften aufweisen | |
| PL374550A1 (en) | Il-17 like molecules and uses thereof | |
| ATE338826T1 (de) | Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression | |
| BRPI0509857A (pt) | agrecanase e proteìna isolada ou recombinante, polinucleotìdeo, kit ou sistema de ensaio, método para identificar um composto capaz de modular a atividade de uma agrecanase, anticorpo, composição, célula hospedeira, método para produzir agrecanase truncada purificada, e, método para o tratamento de uma condição inflamatória em um paciente | |
| AR068038A1 (es) | Polipeptidos de la hormona de crecimiento modificada | |
| WO2007107380A3 (en) | Use of pol iii promoters for controlled expression of therapeutic proteins | |
| IL190028A0 (en) | Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof | |
| WO2008038296A3 (en) | Recombinant calcitonin fused to interleukin-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |